If Americans start paying out of pocket for COVID tests, they’ll test much less — if at all, argue representatives of the Testing at Home Coalition.
Ending free COVID tests risks worsening the pandemic Read More »
The lawsuit comes after the Federal Trade Commission blocked the sale to allow for an antitrust review, despite the system receiving a certificate shielding the acquisition from federal scrutiny.
LCMC Health sues feds for blocking Tulane hospital deal despite securing COPA Read More »
The fight continues as Illumina aims to block Icahn’s nominees from ousting its CEO and board chair.
Illumina slaps back at Icahn’s board nominees, opens proxy collection Read More »
Amid transformation, innovation and buzzwords in value-based care, one crucial area absent is the emergency department, argues Troy Williams, vice president of healthcare systems partnership for First Choice Health.
When will the ER catch up with value-based care? Read More »
Abdera Therapeutics will use the money to fund its ROVEr platform and advance its lead asset ABD-147 for small-cell lung cancer.
Abdera Debuts with $142M to Develop Precision Radiopharmaceuticals Read More »
Kevin Thornal will take the reins from current CEO D. Keith Grossman, who will retire next week.
“We’re not going after anything that’s kind of cool that takes a couple of years to get to the bottom line. This is about immediate returns,” an Advocate Health executive said Wednesday at HIMSS23.
Hospitals look for immediate return on investments in tough operating environment Read More »
Una investigación ha permitido descubrir dos nuevas especies de crustáceos branquiópodos Artemia en Asia. El estudio lo ha realizado un equipo internacional que incluye a especialistas del Instituto de Acuicultura Torre de la Sal (IATS), adscrito al Consejo Superior de …
Descubiertas dos nuevas especies de una rara clase de crustáceos Read More »
Polivy is approved for front-line DLBCL as part of a combination regimen including Rituxan, cyclophosphamide, doxorubicin and prednisone.
FDA Green Lights Roche’s Polivy in First-Line DLBCL Read More »
La forma en que unos genes ‘saltan’ a regiones seguras del genoma podría mejorar la terapia génica contra el cáncer y otras enfermedades. Un equipo internacional liderado por investigadores del Consejo Superior de Investigaciones Científicas (CSIC) en …
Los saltos de los genes y las terapias génicas contra el cáncer Read More »
